Specimen Collection Cards Market Expected to Reach $660.55 Million by 2031.

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Specimen Collection Cards Market- (By Type of Specimen (Blood, Saliva, Urine, Buccal Cells, Others), By Material (Cotton & Cellulose-based, Fiber-based, Others), By Product (Whatman 903, Ahlstrom 226, FTA, Others), By Application (New Born Screening (NBS), Infectious Diseases Testing, Therapeutic Drug Monitoring, Forensics, Research, Wellbeing/Health Monitoring, Other Applications), By Distribution Channel (Online, Offline), By End-Use Channel (Hospitals & Clinics, Diagnostics Centers, Others)) Trends, Industry Competition Analysis, Revenue and Forecast To 2031."

According to the latest research by InsightAce Analytic, the Global Specimen Collection Cards Market is valued at US$ 422.97 Mn in 2022, and it is expected to reach US$ 660.55 Mn by 2031, with a CAGR of 5.2% during a forecast period of 2023-2031.

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1985

Toxicology applications such as toxicokinetics, epidemiology, environmental, and forensic toxicology have all used dried blood spot-collecting cards. In forensic toxicology, dried blood spot collection cards are anticipated to be utilised as a sample preparation technique. They can be inexpensively employed to preserve evidence for closed cases. These cards may also be utilised in the future for screening techniques and the follow-up of markers of clinical or forensic relevance in toxicology. The market for specimen-collecting cards was significantly impacted by the growth of forensic toxicology applications, which led to the widespread acceptance of these cards for reliable and effective sample collection. Due to their simplicity, durability, and ability to hold samples for extended periods, specimen-collecting cards have become increasingly popular in forensic toxicology. They offer a number of advantages, including non-invasiveness, a requirement for smaller sample volumes, and increased sample stability during transportation and storage, all of which improve the accuracy and effectiveness of forensic toxicological testing. The increased emphasis on personalised medicine, genetic testing, health monitoring, and well-being programmes contributes to the market's growth. Personalised medicine seeks to tailor medical treatments for patients based on unique genetic profiles, lifestyle choices, and other pertinent information.

List of Prominent Players in the Specimen Collection Cards Market:
• QIAGEN
• PerkinElmer Inc.
• DBS System SA
• Danaher Corporation
• Eastern Business Forms, Inc.
• Ahlstrom
• ARCHIMED Life Science GmbH
• GenTegra LLC
• FortiusBio
• CENTOGENE N.V.

Market Dynamics:
Drivers-
Important data regarding a patient's health is obtained from laboratory tests. Making accurate diagnoses and treatment decisions depends on the accuracy of test results. Appropriate patient preparation, specimen collection, and processing are necessary for precise test results. The correctness of the test results depends on the specimens' integrity. Laboratory tests are medical examinations that gather data about a patient's health using a variety of laboratory instruments. In order to identify each patient's unique medical condition and decide the most likely course of therapy, these tests need the collection of blood, urine, or other samples from the patients. Clinical chemistry, haematology, DNA testing, and reproductive biology assays are some of the most crucial fields of clinical laboratory testing, Comprehensive metabolic panel, fundamental metabolic panel, and complete blood count (CBC).

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02

Challenges:
Clotting and erroneous volume are two of the most frequent mistakes made during specimen collection and handling. Extreme temperatures may also cause specimens to be excluded from testing. Clotting compromises a specimen's integrity, making it unfit for testing. One of the most frequent issues in specimen collection, for instance, is submitting an inadequate number of samples for testing. The patient is called back for a repeat collection after the laboratory issues a report with the designation QNS (quantity not sufficient), which is difficult for both the patient and the doctor.

Regional Trends:
The North American region held the greatest market share. This results from the increasing need for drug profiling for various drugs, including antiepileptics, immunosuppressants, and antibiotics. It is a major driver of the market's expansion. The existence of deep-rooted healthcare infrastructure and the availability of government financing for research are further factors that are anticipated to foster market progress in this sector.

Recent Developments:
• In August 2022, The Boston Heart Diagnostics Corporation introduced a wide range of tests using dried blood spot collection for a variety of applications, such as type 2 diabetes, cardiovascular risk factors, and wellness evaluations for mental, nutritional, and physical health.
• In June 2022, A study was done to evaluate the effectiveness of Whatman FTA cards in molecular diagnostics for identifying the Yellow Fever Virus (YFV) by a team of researchers from the Division of Vector-Borne Diseases, Fort Collins. According to the study, the card can be inexpensive and simple to use to diagnose yellow fever. Additionally, it enables the doctor to keep viral RNA intact without a cold chain.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1985

Segmentation of Specimen Collection Cards Market-
By Type of Specimen-
• Blood
• Saliva
• Urine
• Buccal Cells
• Others
By Material-
• Cotton & Cellulose-based
• Fiber-based
• Others
By Product-
• Whatman 903
• Ahlstrom 226
• FTA
• Others
By Application-
• New Born Screening (NBS)
• Infectious Diseases Testing
• Therapeutic Drug Monitoring
• Forensics
• Research
• Wellbeing/Health Monitoring
• Other Applications
By Distribution Channel-
• Online
• Offline
By End-Use Channel-
• Hospitals & Clinics
• Diagnostics Centers
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa

Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/1985

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.